EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective

Monika Abramiuk iD, Ilona Skrabalak iD, Malgorzata Satora iD, Marta Ostrowska-Leśko iD, Maja Joanna Czech, Julia Majchrzak, Marcin Bobiński iD

Medical Science Monitor · 2025

DOI: 10.12659/msm.949526 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Monika Abramiuk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Independent Laboratory of Minimally Invasive Gynaecology and Gynaecological Endocrinology, Medical University of Lublin, Lublin, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinoma, Ovarian Epithelial. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial ovarian cancer (EOC) remains a leading cause of gynecologic cancer mortality, with high rates of recurrence and chemoresistance. Advances in understanding the molecular biology of EOC, particularly BRCA mutations and homologous recombination deficiency (HRD), have led to more targeted therapies. This review provides an updated summary of systemic treatments for EOC, with an emphasis on personalized therapy approaches and emerging therapeutic strategies. This review synthesizes current research and clinical trials investigating molecular pathways in EOC, particularly focusing on HRD, BRCA status, and their impact on treatment selection, including the use of PARP inhibitors, chemotherapy, and immunotherapy. Recent studies demonstrate that PARP inhibitors, particularly in patients with BRCA mutations or HRD-positive tumors, have resulted in improved progression-free survival. Ongoing trials combining PARP inhibitors with immunotherapy and angiogenesis inhibitors show promise in extending treatment efficacy and overcoming resistance mechanisms. Despite these advances, recurrence remains common among patients with advanced ovarian cancer. The integration of genetic and molecular insights into systemic treatment is crucial in advancing the management of EOC. While targeted therapies have significantly improved patient outcomes, further research is necessary to optimize treatment strategies and address therapeutic resistance, particularly in patients with non-BRCA-mutated EOC. The future of EOC treatment lies in refining personalized therapies and improving predictive biomarkers for better patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCarcinoma, Ovarian EpithelialHumansFemalePoly(ADP-ribose) Polymerase InhibitorsImmunotherapyMolecular Targeted TherapyMutationNeoplasm Recurrence, LocalPrecision Medicine

Substanzen

Poly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Independent Laboratory of Minimally Invasive Gynaecology and Gynaecological Endocrinology, Medical University of Lublin, Lublin, Poland.
  • Independent Laboratory of Translational Medicine, Medical University of Lublin, Lublin, Poland.
  • 1st Chair and Department of Oncological Gynecology and Gynecology, Students' Scientific Association, Medical University of Lublin, Lublin, Poland.
  • 1st Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin, Poland.

ORCID-Profile: Monika Abramiuk, Ilona Skrabalak, Malgorzata Satora, Marta Ostrowska-Leśko, Marcin Bobiński

Zitieren

APA

Abramiuk, M., Skrabalak, I., Satora, M., Ostrowska-Leśko, M., Czech, M. J., Majchrzak, J., & Bobiński, M. (2025). Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective. Medical Science Monitor. https://doi.org/10.12659/msm.949526

Vancouver

Abramiuk M, Skrabalak I, Satora M, Ostrowska-Leśko M, Czech MJ, Majchrzak J, et al. Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective. Medical Science Monitor. 2025. doi:10.12659/msm.949526

BibTeX
@article{Abramiuk2025,
  author = {Abramiuk, Monika and Skrabalak, Ilona and Satora, Malgorzata and Ostrowska-Leśko, Marta and Czech, Maja Joanna and Majchrzak, Julia and Bobiński, Marcin},
  title = {Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.949526}
}
Kostenlos starten →